Gro-Vida, a key player in Portugal’s medical cannabis sector, has been featured in a special report by SIC Notícias titled “Ouro Verde: O Negócio Milionário e Legal do Cultivo de Canábis para Fins Medicinais,” aired on May 24, 2025. This report showcases Portugal’s rapid ascendance as a hub for medical cannabis cultivation, emphasizing the contributions of Gro-Vida to this burgeoning industry.
As a licensed cultivator of medical-grade cannabis, Gro-Vida operates a state-of-the-art 20,000 square meter hybrid greenhouse, allowing for year-round production. Since receiving its cultivation license in 2019, Gro-Vida has established itself as a pioneer in the Portuguese market, focusing on high-quality standards and pharmaceutical integrity.
Jorge Zambujo, Operations Director at Gro-Vida, expressed pride in the company’s involvement in the SIC Notícias report. He highlighted the importance of public education in reducing the stigma surrounding cannabis. “Cannabis remains a highly stigmatised plant, and overcoming that stigma begins with education,” Zambujo stated. He noted that discussions on national platforms are crucial for advancing understanding of medical cannabis and its role in modern healthcare.
The report also underscored Gro-Vida’s dedication to operational transparency and compliance, positioning the company as a leader in agricultural excellence. Gro-Vida collaborates with other companies in the region to promote responsible cultivation practices, fostering a network of partnerships that includes ongoing dialogue with regulatory authorities.
As demand for medical cannabis continues to grow across Europe, Gro-Vida sets benchmarks for quality and safety. The company offers a diverse range of cannabinoid-based medicines, catering to international markets such as the UK, EU, and Australia. Gro-Vida’s products are certified under Good Agricultural and Collection Practices (GACP) and European Union Good Manufacturing Practice (EU-GMP) standards, ensuring high levels of safety and efficacy.
For those interested in learning more about Gro-Vida’s contributions to the medical cannabis landscape in Portugal, the full SIC Notícias report can be accessed through their website.
English 
Spanish 
German 
Czech